Bruna Tereso Santillo

Bruna Tereso Santillo

Auto-generated profile, based on publicly available information

Bruna Tereso Santillo

Laboratory of Medical Investigation in Dermatology and Immunodeficiences, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
APAlessandra Pontillo
Alessandra Pontillo
BSBruna T Santillo
Bruna T Santillo
ADAlberto Js Duarte
Alberto Js Duarte
TOTelma Oshiro
Telma Oshiro
NLRP3-inflammasome activation was evaluated in monocyte-derived dendritic cells (DC) obtained through IL-4 (IL4-DC) or IFN-α (IFN-DC) protocols and pulsed with chemically inactivated HIV-1. Inflammasome’ genes expression and IL-1β secretion were compared in DC isolated from 15 healthy subjects (HC) and 10 HIV-1 infected individuals (HIV+).

20 December 2018 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
BSBruna Tereso Santillo
Bruna Tereso Santillo
DRDenise da Silva Reis
Denise da Silva Reis
LSLaís Teodoro da Silva
Laís Teodoro da Silva
NRNathalia Teixeira Romani
Nathalia Teixeira Romani
ADAlberto José da Silva Duarte
Alberto José da Silva Duarte
TOTelma Miyuki Oshiro
Telma Miyuki Oshiro
Dendritic cell (DC)-based immunotherapy is a promising strategy for the treatment of HIV-infected individuals. Different from the conventional protocol for DC differentiation based on the cytokine IL-4 (IL4-DCs), several studies have suggested obtaining DCs by culturing monocytes with type I IFN (IFN-α) to yield IFN-DCs, as performed in cancer therapy. To evaluate the phenotypic and functional characteristics, monocytes from HIV-infected subjects were differentiated into IFN-DCs or IL4-DCs, pulsed with chemically inactivated HIV and stimulated with pro-inflammatory cytokines. A comparative analysis between both types of monocyte-derived DCs (MoDCs) showed that immature IFN-DCs were phenotypically distinct from immature IL4-DCs at the baseline of differentiation, presenting a pre-activated profile. From the functional profile, we determined that IFN-DCs were capable of producing the cytokine IL-12 p70 and of inducing the production of IFN-γ by CD4 + T lymphocytes but not by TCD8+ lymphocytes. Our results suggest that IFN-DCs derived from HIV-infected individuals are able to recognize and present viral antigens to induce TCD4+ cellular immunity to HIV.

7 May 2024 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
KYKelly Yoshizaki
Kelly Yoshizaki
DFDaniela Perroni Frias
Daniela Perroni Frias
KMKevin Maier
Kevin Maier
JSJuliana Smelan
Juliana Smelan
ACAristides Correia
Aristides Correia
MMMariangela Macchione
Mariangela Macchione

19 May 2016 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CLCarolina G. D. O. Lucas
Carolina G. D. O. Lucas
FMFlavio L. Matassoli
Flavio L. Matassoli
LPLigia M. T. Peçanha
Ligia M. T. Peçanha
BSBruna Tereso Santillo
Bruna Tereso Santillo
LOLuanda Oliveira
Luanda Oliveira
LALuciana Arruda
Luciana Arruda
The decline in number and function of T cells is a hallmark of HIV infection, and preservation or restoration of HIV‐specific cellular immune response is a major goal of AIDS treatment. Dendritic cells (DCs) play a key role in the initiation and maintenance of the immune response, and their use as a vaccine vehicle is a promising strategy for enhancing vaccine efficacy. We evaluated the potential of DC‐mediated immunization with a DNA vaccine consisting of HIV‐1‐p55gag (gag, group‐specific antigen) associated to lysosomal associated protein (LAMP) sequence (LAMP/ gag vaccine). Immunization of mice with mouse DCs transfected with LAMP/gag (Lg‐mDCs) stimulated more potent B‐ and T‐cell responses than naked DNA or DCs pulsed with inactivated HIV. Anti‐Gag antibody levels were sustained for at least 3 mo after immunization, and recall T‐cell responses were also strongly detected at this time point. Human DCs transfected with LAMP/ gag (Lg‐hDCs) were also activated and able to stimulate greater T‐cell response than native gag ‐transfected DCs. Coculture between Lg‐hDCs and T lymphocytes obtained from patients with HIV resulted in upregulation of CD38, CD69, HLA‐DR, and granzyme B by CD4 + and CD8 + T cells, and increased IFN‐γ and TNF‐α production. These results indicate that the use of LAMP/ gag ‐DC may be an efficient strategy for enhancing immune function in patients with HIV.—Lucas, C. G. D. O., Matassoli, F. L., Peçanha, L. M. T., Santillo, B. T., Oliveira, L. M. D. S., Oshiro, T. M., Marques, E. T. D. A., Jr., Oxenius, A., de Arruda, L. B. Dendritic cells primed with a chimeric plasmid containing HIV‐1‐gag associated with lysosomal‐associated protein‐1 (LAMP/ gag ) is a potential therapeutic vaccine against HIV. FASEB J. 30, 2970‐2984 (2016). www.fasebj.org